Doses of Wegovy - Search News

Medicare targets popular weight loss drugs Ozempic, Wegovy

Tripling Wegovy dosage leads to more weight loss, Novo Nordisk trial shows

Tripling the dosage of the Wegovy weight-loss drug leads to more weight loss, Novo Nordisk said Friday. The Danish drugmaker announced results from a Phase 3B trial of semaglutide at a 7.2 milligram dosage,

USA TODAY on MSN · 8h

Medicare targets popular weight loss drugs Ozempic, Wegovy for price negotiations

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, diabetes and asthma.

Reuters on MSN · 2h

Explainer-What Wegovy's inclusion in Medicare price negotiation means for patients, company

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027, which includes Novo Nordisk's blockbuster weight-loss drug Wegovy.Here's

High-dose Wegovy leads to substantial weight loss in trial

Wall Street Journal · 10h

Wegovy at Higher Dose Achieves Greater Weight Loss in Trial

Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, without experiencing an increase in side effects.

STAT · 10h

High-dose Wegovy leads to substantial weight loss in trial, but falls short of Zepbound

A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less than what’s been seen with Zepbound.

Benzinga.com · 11h

Novo Nordisk's Higher Dose Of Wegovy Shows Roughly 21% Weight Loss

Novo Nordisk's STEP UP trial shows semaglutide 7.2 mg delivers superior weight loss and safety compared to lower doses and placebo over 72 weeks.

8hon MSN

Novo’s Wegovy Trails Lilly’s Rival in High-Dose Study

Novo Nordisk A/S’s blockbuster drug Wegovy was targeted for price cuts by the US government and suffered a setback in a new ...

8hon MSN

Ozempic, Wegovy and other drugs are among 15 selected for Medicare’s price negotiations

The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of ...

BioPharma Dive4h

Novo shares high-dose Wegovy results; Amgen, AstraZeneca drugs get expanded OKs

A high-dose form of Novo’s obesity drug led to 20% weight loss over 72 weeks. Meanwhile, Atara got a complete response letter and Boehringer reported a Phase 3 failure.

Ozempic and Wegovy among drugs on Medicare list getting price cuts

The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Medicare targets popular weight loss drugs Ozempic, Wegovy

High-dose Wegovy leads to substantial weight loss in trial

Related topics